Abstract

Immune Checkpoint Inhibitor Therapy for Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes: A Single-Center Experience

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
The Impact of PHF6 Mutations in Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia
Kelly Soltysiak ... Yesid Alvarado
Blood | VOL. 134
Kelly Soltysiak, et. al.Kelly Soltysiak ... Yesid Alvarado
13 Nov 2019
Early Results from a Biomarker-Directed Phase 2 Trial of Sy-1425 in Combination with Azacitidine or Daratumumab in Non-APL Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Kristin Stephens ... Jane L Liesveld
Blood | VOL. 132
Kristin Stephens, et. al.Kristin Stephens ... Jane L Liesveld
29 Nov 2018
Interim Analysis of Phase II Study of Venetoclax with 10-Day Decitabine (DEC10-VEN) in Acute Myeloid Leukemia and Myelodysplastic Syndrome
Steven M Kornblau ... Yesid Alvarado
Blood | VOL. 132
Steven M Kornblau, et. al.Steven M Kornblau ... Yesid Alvarado
29 Nov 2018
Healthcare Resource Utilization (HCRU) in Patients (pts) with Newly Diagnosed (ND) Acute Myeloid Leukemia (AML) Treated in the Connect® MDS/AML Disease Registry
Melissa Nifenecker ... Pavel Kiselev
Blood | VOL. 132
Melissa Nifenecker, et. al.Melissa Nifenecker ... Pavel Kiselev
29 Nov 2018
View more papers

More From: Blood

Paper Title
Journal
Date
Author
Mutational profile of previously treated chronic lymphocytic leukemia patients progressing on acalabrutinib or ibrutinib.
Jennifer A Woyach ... Veerendra Munugalavadla
Blood | VOL. -
Jennifer A Woyach, et. al.Jennifer A Woyach ... Veerendra Munugalavadla
16 May 2024
Outcomes of younger patients with mantle-cell lymphoma experiencing late relapse (>24 months): the LATE-POD study.
Chiara Malinverni ... Carlo Visco
Blood | VOL. -
Chiara Malinverni, et. al.Chiara Malinverni ... Carlo Visco
16 May 2024
How I manage pregnant patients who are alloimmunized to RBC antigens.
Helen Frances Savoia ... Stefan Charles Kane
Blood | VOL. -
Helen Frances Savoia, et. al.Helen Frances Savoia ... Stefan Charles Kane
14 May 2024
Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma
Ross S Firestone ... David J Chung
Blood | VOL. -
Ross S Firestone, et. al.Ross S Firestone ... David J Chung
10 May 2024
View more papers